Who owns the OXYSTEROL THERAPEUTICS trademark?

The OXYSTEROL THERAPEUTICS trademark is owned by MAX BioPharma, Inc..

What class is the OXYSTEROL THERAPEUTICS trademark registered in?

The OXYSTEROL THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for OXYSTEROL THERAPEUTICS?

The USPTO serial number for OXYSTEROL THERAPEUTICS is 86746639.

What is the registration number for OXYSTEROL THERAPEUTICS?

OXYSTEROL THERAPEUTICS is registered under USPTO registration number 5152047.

OXY

USPTO Trademark Record

REGISTERED

OXYSTEROL THERAPEUTICS

SN 86746639·Reg 5152047·Filed Sep 03, 2015

Owner MAX BioPharma, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

OXYSTEROL THERAPEUTICS (Serial No. 86746639), Registration No. 5152047, is a registered US trademark filed on Sep 03, 2015 by MAX BioPharma, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Deadline expired: October 15, 2024

Mark Intelligence

OXYSTEROL THERAPEUTICS (Reg. #5152047) is a registered US trademark that has been protecting its owner, MAX BioPharma, Inc., since 2015. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 03, 2015

SERIAL

86746639

REG#

5152047

REGISTERED

Feb 28, 2017

Owner

Applicant

MAX BioPharma, Inc.

Entity

Corporation

State

Address

612 South Barrington Ave., Ste 212, Los Angeles, CA, 90049

Country

Attorney

Law firm

MAX BioPharma, Inc.

Address

612 South Barrington Ave., Ste 212, Los Angeles, CA 90049, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 03, 2015

Serial Number86746639

Registration No.5152047

Registration DateFeb 28, 2017

Status DateFeb 28, 2017

Published for OppositionMar 01, 2016

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2015

YEARS AGO

11y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Apr 30, 2011

First use in commerce: Apr 30, 2011

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

42 events

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

Aug 19, 2025

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

CORRECTION UNDER SECTION 7 - PROCESSED

Jul 31, 2025

CORRECTION UNDER SECTION 7 - PROCESSED

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

Apr 10, 2025

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

POST REGISTRATION ACTION CORRECTION

Apr 08, 2025

POST REGISTRATION ACTION CORRECTION

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

Apr 07, 2025

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

POST REGISTRATION ACTION MAILED - SEC. 7

Oct 07, 2024

POST REGISTRATION ACTION MAILED - SEC. 7

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

Sep 26, 2024

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

POST REGISTRATION ACTION MAILED - SEC. 7

Apr 15, 2024

POST REGISTRATION ACTION MAILED - SEC. 7

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Apr 08, 2024

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 7 REQUEST RECEIVED

Aug 29, 2023

TEAS SECTION 7 REQUEST RECEIVED

TEAS SECTION 8 RECEIVED

Aug 25, 2023

TEAS SECTION 8 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Feb 28, 2022

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Feb 28, 2017

REGISTERED-PRINCIPAL REGISTER

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 25, 2017

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 25, 2017

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 24, 2017

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 23, 2017

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

ASSIGNED TO LIE

Jan 19, 2017

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 19, 2017

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 19, 2017

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 19, 2016

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 29, 2016

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Jun 29, 2016

NON-FINAL ACTION E-MAILED

SU - NON-FINAL ACTION - WRITTEN

Jun 29, 2016

SU - NON-FINAL ACTION - WRITTEN

STATEMENT OF USE PROCESSING COMPLETE

Jun 24, 2016

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 23, 2016

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

May 31, 2016

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

May 31, 2016

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 26, 2016

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 01, 2016

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 01, 2016

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 10, 2016

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 04, 2016

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 30, 2015

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 29, 2015

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 29, 2015

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Dec 18, 2015

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 18, 2015

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 18, 2015

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Dec 16, 2015

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 09, 2015

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 07, 2015

NEW APPLICATION ENTERED

OXYSTEROL THERAPEUTICS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by MAX BioPharma, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Resources

Company